TREATMENT FAILURES OF CEFOTAXIME AND LATAMOXEF IN MENINGITIS CAUSED BY ENTEROBACTER AND SERRATIA SPP

被引:27
|
作者
ENG, RHK
CHERUBIN, CE
PECHERE, JC
BEAM, TR
机构
[1] UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,NEWARK,NJ 07103
[2] SUNY BUFFALO,DEPT MED,BUFFALO,NY 14215
[3] UNIV GENEVA,MED CTR,DEPT MICROBIOL,CH-1211 GENEVA 4,SWITZERLAND
[4] VET ADM MED CTR,INFECT DIS SECT,BUFFALO,NY 14215
[5] BAYLEY SETON HOSP,DEPT MED,STATEN ISL,NY 10304
关键词
D O I
10.1093/jac/20.6.903
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:903 / 911
页数:9
相关论文
共 50 条
  • [31] SUCCESSFUL TREATMENT OF NEONATAL MENINGITIS WITH CEFOTAXIME - A CASE-REPORT
    ALNAJDI, AA
    ALEISSA, IS
    KHUFFASH, FA
    JOURNAL OF THE KUWAIT MEDICAL ASSOCIATION, 1985, 19 (01): : 81 - 82
  • [32] 3 CASES OF NEONATAL MENINGITIS CAUSED BY ENTEROBACTER-SAKAZAKII IN POWDERED MILK
    BIERING, G
    KARLSSON, S
    CLARK, NC
    JONSDOTTIR, KE
    LUDVIGSSON, P
    STEINGRIMSSON, O
    JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (09) : 2054 - 2056
  • [33] EFFECTS OF PREGERMINATION OF PEA AND CUCUMBER SEEDS AND OF SEED TREATMENT WITH ENTEROBACTER-CLOACAE ON ROTS CAUSED BY PYTHIUM SPP
    HADAR, Y
    HARMAN, GE
    TAYLOR, AG
    NORTON, JM
    PHYTOPATHOLOGY, 1983, 73 (09) : 1322 - 1325
  • [34] Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain
    Vandecasteele, SJ
    Verhaegen, J
    Colaert, J
    Van Caster, A
    Devlieger, H
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (10) : 751 - 752
  • [35] Draft Genome Sequences of Enterobacter spp., Lelliottia spp., and Serratia spp., Coliform Bacteria from Drinking Water Reservoirs and Lakes
    Reitter, Carolin
    Neuhaus, Klaus
    Huegler, Michael
    MICROBIOLOGY RESOURCE ANNOUNCEMENTS, 2021, 10 (32):
  • [36] Failure of Cefotaxime and Meropenem to Eradicate Meningitis Caused by an Intermediately Susceptible Streptococcus pneumoniae Strain
    S. Vandecasteele
    J. Verhaegen
    J. Colaert
    A. Caster
    H. Devlieger
    European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 : 751 - 752
  • [37] Nosocomial enterobacter meningitis: Risk factors, management, and treatment outcomes
    Parodi, S
    Lechner, A
    Osih, R
    Vespa, P
    Pegues, D
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 159 - 166
  • [38] MENINGITIS CAUSED BY KLEBSIELLA SPP IN 2 RHESUS-MONKEYS
    FOX, JG
    ROHOVSKY, MW
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1975, 167 (07): : 634 - 636
  • [39] Serratia marcescens meningitis: Epidemiology, prognostic factors and treatment outcomes
    Wu, Yen-Mu
    Hsu, Po-Chang
    Yang, Chien-Chang
    Chang, Hong-Jyun
    Ye, Jung-Jr
    Huang, Ching-Tai
    Lee, Ming-Hsun
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2013, 46 (04) : 259 - 265
  • [40] CLINICAL-EVALUATION OF CEFOTAXIME IN THE TREATMENT OF PURULENT-MENINGITIS IN CHILDREN
    KOBAYASHI, Y
    MORIKAWA, Y
    HARUTA, T
    FUJII, R
    MEGURO, H
    HORI, M
    KUROSU, Y
    TOYONAGA, Y
    IWAI, N
    KITAMURA, I
    HAMAWAKI, M
    OZAKI, H
    JAPANESE JOURNAL OF ANTIBIOTICS, 1981, 34 (06): : 946 - 954